RICHMOND, Calif., Apr. 4 (Korea Bizwire) — Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries [...]
RICHMOND, Calif., Jun. 25 (Korea Bizwire) — Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that the latest Ekso Bionics robotic gait therapy software upgrade, first available in Europe, will be revealed at the 28th Annual Meeting of the German Speaking Medical Society for Paraplegia (DMGP) in Kassel, Germany. The four-day congress [...]
RICHMOND, Calif., Jun. 3 (Korea Bizwire) — Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that their participation in Rehab Week 2015, Valencia Spain, will kick off with an inaugural Ekso Clinical Science Organization (ECSO) meeting. This group will lay the groundwork for the clinical evidence roadmap necessary to become part of [...]